Up-Regulation of miR-370-3p Restores Glioblastoma Multiforme Sensitivity to Temozolomide by Influencing MGMT Expression

Scientific Reports - United Kingdom
doi 10.1038/srep32972
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Overexpression miR-486-3p Promoted by Allicin Enhances Temozolomide Sensitivity in Glioblastoma via Targeting MGMT

NeuroMolecular Medicine
Molecular NeuroscienceNeurologyMolecular MedicineCellular
2020English

JNK Contributes to Temozolomide Resistance of Stem-Like Glioblastoma Cells via Regulation of MGMT Expression

International Journal of Oncology
Cancer ResearchOncology
2013English

A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Sulforaphane Reverses Chemo-Resistance to Temozolomide in Glioblastoma Cells by NF-κB-dependent Pathway Downregulating MGMT Expression

International Journal of Oncology
Cancer ResearchOncology
2015English

Silencing Hsa_circ_PVT1 (circPVT1) Suppresses the Growth and Metastasis of Glioblastoma Multiforme Cells by Up-Regulation of miR-199a-5p

Artificial Cells, Nanomedicine and Biotechnology
MedicineBiotechnologyBiomedical EngineeringPharmaceutical Science
2019English

circRNA_001275 Upregulates Wnt7a Expression by Competitively Sponging miR‑370‑3p to Promote Cisplatin Resistance in Esophageal Cancer

International Journal of Oncology
Cancer ResearchOncology
2020English

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

PLoS ONE
Multidisciplinary
2015English

Erratum To: MGMT Inhibition Restores ERα Functional Sensitivity to Antiestrogen Therapy

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2012English

miR-152-3p Sensitizes Glioblastoma Cells Towards Cisplatin via Regulation of SOS1

OncoTargets and Therapy
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy